Blog
42
blog,bridge-core-3.1.3,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-30.2,qode-theme-bridge,wpb-js-composer js-comp-ver-7.3,vc_responsive

The Bulgarian Drug Agency (BDA) officially joined the PIC/S - Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme as its 55th Participating Authority, effective from July 1, 2023. PIC/S is a non-binding co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of...

We are pleased to announce that, in order to facilitate the growth of our team, we have relocated our business to a new location. With easy access from the airport and a nearby Metro station, as well as a much larger parking lot available to...

In January 2023 EMA posted an interesting interpretation of the Pharmacovigilance Inspectors Working Group regarding Day 0 in the context of Individual Case Safety Reports (ICSRs) found in physical/hard copy local medical journals: “For ICSRs, described in the medical literature containing the minimum criteria, the clock...

We celebrated our 15th anniversary at the end of 2022! We started the company with the idea to tailor our services to the needs of the different types of companies we serve while taking into consideration the particularities of the local markets we operate in....

We are glad to announce that PharmDedict is now part of the family of the Digital Health and Innovations Cluster Bulgaria. The DHI Cluster is a non-profit organization that supports companies and organizations in the field of digital solutions and innovations in healthcare to build...

In order to achieve the most effective resolution of all regulatory matters, we have chosen to conduct business in a network of selected nationally based companies in almost all of the member states of the European Union plus Norway, Switzerland and Lichtenstein. We are proud to...